← FDA Drug Approvals (Drugs@FDA)

AMIKACIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2015-12-09

Drug application

FDA Application #
ANDA205604
Application type
Abbreviated New Drug Application (Generic)
Brand name
AMIKACIN SULFATE
Generic name
AMIKACIN SULFATE
Active ingredients
AMIKACIN SULFATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2015-12-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown